Neximmune Probability of Future Pink Sheet Price Finishing Over 10.87
| NEXIDelisted Stock | USD 2.43 0.22 9.95% |
Neximmune |
Neximmune Target Price Odds to finish over 10.87
The tendency of Neximmune Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 10.87 or more in 90 days |
| 2.43 | 90 days | 10.87 | close to zero percent |
Based on a normal probability distribution, the odds of Neximmune to move over $ 10.87 or more in 90 days from now is close to zero percent (This Neximmune probability density function shows the probability of Neximmune Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Neximmune price to stay between its current price of $ 2.43 and $ 10.87 at the end of the 90-day period is over 95.71 .
Given the investment horizon of 90 days Neximmune has a beta of -0.87. This indicates Additionally Neximmune has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Neximmune Price Density |
| Price |
Predictive Modules for Neximmune
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Neximmune. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Neximmune's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Neximmune Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Neximmune is not an exception. The market had few large corrections towards the Neximmune's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Neximmune, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Neximmune within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.22 | |
β | Beta against Dow Jones | -0.87 | |
σ | Overall volatility | 0.39 | |
Ir | Information ratio | -0.04 |
Neximmune Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Neximmune for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Neximmune can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Neximmune is not yet fully synchronised with the market data | |
| Neximmune has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (32.34 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Neximmune currently holds about 53.13 M in cash with (31.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.2. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
Neximmune Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Neximmune Pink Sheet often depends not only on the future outlook of the current and potential Neximmune's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Neximmune's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1 M | |
| Cash And Short Term Investments | 4.6 M |
Neximmune Technical Analysis
Neximmune's future price can be derived by breaking down and analyzing its technical indicators over time. Neximmune Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Neximmune. In general, you should focus on analyzing Neximmune Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Neximmune Predictive Forecast Models
Neximmune's time-series forecasting models is one of many Neximmune's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Neximmune's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Neximmune
Checking the ongoing alerts about Neximmune for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Neximmune help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Neximmune is not yet fully synchronised with the market data | |
| Neximmune has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (32.34 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Neximmune currently holds about 53.13 M in cash with (31.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.2. | |
| Roughly 17.0% of the company outstanding shares are owned by corporate insiders |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Neximmune Pink Sheet
If you are still planning to invest in Neximmune check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neximmune's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |